PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.\', \'Department of Neurosurgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.\', \'Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.\', \'Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.\', \'Department of Microbiology, University of Pennsylvania, Philadelphia, PA.\', \'Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.\', \'Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.\', \'Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1200/OP.21.00113
?:hasPublicationType
?:journal
  • JCO oncology practice
is ?:pmid of
?:pmid
?:pmid
  • 34133219
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed Therapy.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all